18-11689831-A-G
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_182978.4(GNAL):c.268A>G(p.Lys90Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000143 in 1,537,564 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 11/16 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_182978.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GNAL | NM_182978.4 | c.268A>G | p.Lys90Glu | missense_variant | 1/12 | ENST00000334049.11 | NP_892023.1 | |
GNAL | XM_006722324.4 | c.268A>G | p.Lys90Glu | missense_variant | 1/6 | XP_006722387.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GNAL | ENST00000334049.11 | c.268A>G | p.Lys90Glu | missense_variant | 1/12 | 1 | NM_182978.4 | ENSP00000334051.5 | ||
GNAL | ENST00000585590.1 | n.142A>G | non_coding_transcript_exon_variant | 1/2 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 151916Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000354 AC: 5AN: 141210Hom.: 0 AF XY: 0.0000382 AC XY: 3AN XY: 78554
GnomAD4 exome AF: 0.0000144 AC: 20AN: 1385648Hom.: 0 Cov.: 32 AF XY: 0.0000146 AC XY: 10AN XY: 685480
GnomAD4 genome AF: 0.0000132 AC: 2AN: 151916Hom.: 0 Cov.: 33 AF XY: 0.0000135 AC XY: 1AN XY: 74218
ClinVar
Submissions by phenotype
Dystonic disorder Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 29, 2018 | This sequence change replaces lysine with glutamic acid at codon 90 of the GNAL protein (p.Lys90Glu). The lysine residue is weakly conserved and there is a small physicochemical difference between lysine and glutamic acid. The GNAL gene has multiple clinically relevant isoforms. The c.268A>G variant occurs in alternate transcript NM_182978.3, which corresponds to position c.-61978A>G in NM_001142339.2, the primary transcript listed in the Methods. The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the ExAC database. This variant has not been reported in the literature in individuals with GNAL-related disease. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at